Results 81 to 90 of about 6,768,795 (300)

Influenza Vaccination Responses in Disabled Stroke Patients: A Single‐Center Prospective Observational Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to investigate the immunological response to influenza vaccination, the incidence and severity of influenza infection, and the side effects of the vaccination in patients with ischemic stroke. Methods This prospective observational study was conducted between 2023 and 2024 at Ramathibodi Hospital.
Achiraya Pakngao, Sureerat Suwatcharangoon, Pintip Ngamjanyapron, Kobporn Boonnak, Thanitta Suangtamai, Porpon Rotjanapan   +5 more
wiley   +1 more source

Enhancement of antimicrobial activities of whole and sub-fractionated white tea by addition of copper (II) sulphate and vitamin C against Staphylococcus aureus; a mechanistic approach

BMC Complementary and Alternative Medicine, 2011
Background Enhancement of antimicrobial plant products e.g. pomegranate extract by copper (II) sulphate is known. Such combinations have applications in various settings, including the identification of novel compositions to study, treat and control ...
Holloway Andrew C, Gould Simon WJ, Fielder Mark D, Naughton Declan P, Kelly Alison F   +4 more
doaj   +1 more source

XAFS spectrum of Copper(II) chloride dihydrate

This dataset consists of X-ray absorption fine structure (XAFS) spectra at Cu K-edge of Copper(II) chloride dihydrate measured at Photon Factory BL-12C, and is a part of XAFS database (MDR XAFS DB, https://doi.org/10.48505/nims.1447) as a collection of ...
Yasuhiro Inada
core   +1 more source

Stage‐Dependent β‐Synuclein Links MRI and Cognitive Decline in Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Synaptic degeneration drives cognitive decline in Alzheimer's disease (AD), but synaptic biomarkers are scarce. Brain‐enriched β‐synuclein emerged as a synaptic damage marker. We investigated its diagnostic, prognostic, and structural correlates across the AD continuum.
Ulaş Ay, Merve Alaylioglu, Erdi Sahin, Sanem Sultan Yoruk Oner, Gulce Iskan, Gulce Cosku Yilmaz Cakan, Gozde Kizilates‐Evin, Emre Hari, Elif Kurt, Erdinc Dursun, Basar Bilgic, Hasmet Hanagasi, Hakan Gurvit, Tamer Demiralp, Duygu Gezen‐Ak, Bedia Samanci   +15 more
wiley   +1 more source

XAFS spectrum of Copper(II) chloride, anhydrous

This dataset consists of X-ray absorption fine structure (XAFS) spectra at Cu K-edge of Copper(II) chloride, anhydrous measured at Photon Factory BL-12C, and is a part of XAFS database (MDR XAFS DB, https://doi.org/10.48505/nims.1447) as a collection of ...
Yasuhiro Inada
core   +1 more source

The Association of Amyloid‐β and Tau With Synaptic Dysfunction in Alzheimer's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To clarify the relative contributions of amyloid and tau to synaptic dysfunction in Alzheimer's disease (AD). Methods We included 109 cognitively unimpaired and impaired individuals from the Geneva Memory Center with available CSF synaptic biomarkers (neurogranin, SNAP‐25, GAP‐43). Participants were stratified according to amyloid (A)
Fausto Roveta, Augusto J. Mendes, Valentina Garibotto, Cecilia Boccalini, Aurelien Lathuiliere, Innocenzo Rainero, Elisa Rubino, Henrik Zetterberg, Nicholas J. Ashton, Federica Ribaldi, Giovanni B. Frisoni, for the Alzheimer's Disease Neuroimaging Initiative   +11 more
wiley   +1 more source

A Two‐Stage Plasma Biomarker Algorithm Reduces Amyloid PET Use and the p‐Tau217 Gray Zone

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Plasma p‐Tau217 leaves 30%–50% of patients in an indeterminate “gray zone” often requiring Aβ‐PET. We developed GRAD (Gatekeeper‐Reflex for Alzheimer's Disease), a two‐stage Aβ‐positivity prediction model to improve classification while reserving Aβ‐PET for residual uncertainty.
Harthik Parankusham, Casey Vanderlip, Colin Birkenbihl, Eashwar Krishna, Chizobam Ugboaja, Andrew E. Budson, Brandon Frank, for the Alzheimer's Disease Neuroimaging Initiative   +7 more
wiley   +1 more source

Improving the Diagnostic Accuracy of Plasma Alzheimer's Disease Biomarkers With Objective and Subjective Cognitive Screening

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Blood‐based biomarkers are increasingly used to identify Alzheimer's disease (AD) pathology and may play an important role in early disease screening and participant selection for clinical trials. However, their performance across stages of cognitive impairment remains unclear. This study examined whether plasma biomarkers differ in
Maryam Abdolmaleki, Leslie S. Gaynor, Dandan Liu, Timothy J. Hohman, Katherine A. Gifford, Henrik Zetterberg, Angela L. Jefferson, Corey J. Bolton   +7 more
wiley   +1 more source

3-Nitroso-4-hydroxy-5,6-benzocoumarin (NHBC) as a reagent for the spectrophotometric determination of copper(II) in alloys

CHIMIA, 1974
Copper(II) forms in the pH range 6.3 to 7.8 a yellowish brown complex with 3-nitroso-4-hydroxy-5,6-benzocoumarin which is soluble in a 60 % dioxan medium giving a deep yellow coloured solution. Beer’s law is obeyed up to 2.80 ppm of copper(II) at 420 nm.
Nitin Kohli, R.P. Singh
doaj   +1 more source

Synthesis, magnetic and spectral properties of binuclear imidazolate bridged copper(II)-copper(II) and copper(II)-zinc(II) complexes

, 2001
Department of Chemistry, A P. S. University, Rewa-486 003, India Manuscript received 1 November 1999, revised 17 April 2000. accepted 26 August 2000 Two new binuclear imidazolate bridged complexes, [(PAN)Cu(im)Cu(PAN)] (ClO4)2 and [(PAN)Cu(im)Zn(PAN)](ClO4)2 (PAN =1. (2-pyridylazo)-2-naphthol, im = imidazolate) have been prepared.
Ram N. Patel, Ayodhya P. Patel, Krishna B. Pandeya   +2 more
openaire   +2 more sources